Celiac Disease Opportunity Analysis and Forecast to 2023

Opportunity Analyzer: Celiac Disease â&#x20AC;&#x201C; Opportunity Analysis and Forecast to 2023 By RnRMarketResearch

Browse more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals ÂŠ http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Opportunity Analyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023 There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immuno suppressants are used to reduce symptoms in severe cases, targeting approximately 5% of the celiac disease patient population and there are no preventative medications. The anticipated launch of Alba/Teva’s larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie’s latiglutenase in 2019 and 2020 in the US and 5EU respectively are set to change the management of the disease and drive growth in the celiac disease market. Complete report available at http://www.rnrmarketresearch.com/opportunityanalyzer-celiac-diseaseopportunity-analysis-and-forecast-to-2023-market-report.html .

Opportunity Analyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023 Key Questions Answered:• How will the celiac disease market landscape change within the 2013-2018 and the 2013-2023 forecast periods in the 6MM? • What are the most promising late-stage pipeline drugs and how will their launch shape the future treatment landscape in the celiac disease market? • How do the clinical and commercial attributes of late-stage pipeline drugs compare to one another and against existing treatment options? • What are the significant unmet needs in the celiac disease market?

Opportunity Analyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023 Scope: • Overview of celiac disease, including epidemiology, etiology, pathophysiology, symptoms and current treatment options • Annualized celiac disease therapeutics market revenue, annual cost of therapies and forecasts for five years to 2018 and ten years to 2023. • Key topics covered include strategic product assessment, market characterization, unmet needs, R&D strategies, clinical trial design and implications for the celiac disease therapeutics market.

Opportunity Analyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023 Reasons to Buy:

• Identify the unmet needs and remaining opportunities in the celiac disease therapeutics market. • Develop business strategies by understanding the trends shaping and driving the US and five major EU celiac disease therapeutics market. • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. • Assess the clinical and commercial viability of promising pipeline products.

Opportunity Analyzer: Celiac Disease â&#x20AC;&#x201C; Opportunity Analysis and Forecast to 2023

For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441

RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.

ÂŠ http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Turn static files into dynamic content formats.

Create a flipbook